Targeted degradation of the androgen receptor in prostate cancer

被引：0
|
作者：
Jin, Meizhong [1 ]
Winkler, James D. [1 ]
Coleman, Kevin [1 ]
Crew, Andrew P. [1 ]
Rossi, AnnMarie K. [1 ]
Willard, Ryan R. [1 ]
Dong, Hanqing [1 ]
Siu, Kam [1 ]
Wang, Jing [1 ]
Gordon, Deborah A. [1 ]
Chen, Xin [1 ]
Ferraro, Caterina [1 ]
Crews, Craig M. [2 ]
Neklesa, Taavi K. [1 ]
机构：
[1] Arvinas Inc, New Haven, CT USA
[2] Yale Univ, New Haven, CT USA
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-LB-097
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB-097
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Combinatorial androgen receptor targeted therapy for prostate cancer
    Singh, P.
    Uzgare, A.
    Litvinov, I.
    Denmeade, S. R.
    Isaacs, J. T.
    [J]. ENDOCRINE-RELATED CANCER, 2006, 13 (03) : 653 - 666
  • [2] Advances in Androgen Receptor Targeted Therapy for Prostate Cancer
    Ahmed, Alia
    Ali, Shadan
    Sarkar, Fazlul H.
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 2014, 229 (03) : 271 - 276
  • [3] Androgen receptor degradation (ARD) enhancers: a targeted therapy for hormone- refractory prostate cancer
    Su, Ching-Yuan
    Russell, Brian
    Cao, Richard
    Wang, Hui-Kang
    Shih, Charles C-Y.
    [J]. CANCER RESEARCH, 2006, 66 (08)
  • [4] Targeted combinatorial therapy of androgen receptor in androgen independent prostate cancer cells
    Gomez-Pinillos, A.
    Liu, X.
    Ferrari, A. C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [5] Evolution of androgen receptor targeted therapy for advanced prostate cancer
    Yien Ning Sophia Wong
    Roberta Ferraldeschi
    Gerhardt Attard
    Johann de Bono
    [J]. Nature Reviews Clinical Oncology, 2014, 11 : 365 - 376
  • [6] Evolution of androgen receptor targeted therapy for advanced prostate cancer
    Wong, Yien Ning Sophia
    Ferraldeschi, Roberta
    Attard, Gerhardt
    de Bono, Johann
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2014, 11 (06) : 365 - 376
  • [7] Degradation of Androgen Receptor through Small Molecules for Prostate Cancer
    Ge, Raoling
    Xu, Xi
    Xu, Pengfei
    Li, Lei
    Li, Zhiyu
    Bian, Jinlei
    [J]. CURRENT CANCER DRUG TARGETS, 2018, 18 (07) : 652 - 667
  • [8] Targeted androgen receptor (AR) protein degradation for the treatment of metastatic castration-resistant prostate cancer (mCRPC)
    Han, Xin
    Zhao, Lijie
    Xiang, Weiguo
    Qin, Chong
    Miao, Bukeyan
    Xu, Tianfeng
    Lu, Jianfeng
    Wang, Mi
    Wang, Shaomeng
    [J]. CANCER RESEARCH, 2020, 80 (16)
  • [9] A Targeted Bivalent Androgen Receptor Binding Compound for Prostate Cancer Therapy
    Chowdhury, Shafinaz
    Beitel, Lenore K.
    Lumbroso, Rose
    Purisima, Enrico O.
    Paliouras, Miltiadis
    Trifiro, Mark
    [J]. HORMONES & CANCER, 2019, 10 (01): : 24 - 35
  • [10] A Targeted Bivalent Androgen Receptor Binding Compound for Prostate Cancer Therapy
    Shafinaz Chowdhury
    Lenore K. Beitel
    Rose Lumbroso
    Enrico O. Purisima
    Miltiadis Paliouras
    Mark Trifiro
    [J]. Hormones and Cancer, 2019, 10 : 24 - 35
12345